As La Jolla Pharmaceutical Co (LJPC) Stock Declined, Shareholder Broadfin Capital Has Boosted Its Stake; Range Res (RRC) Holding Held by Quaker Capital Investments Llc

Range Resources Corporation (NYSE:RRC) Logo

Broadfin Capital Llc increased its stake in La Jolla Pharmaceutical Co (LJPC) by 37.43% based on its latest 2018Q3 regulatory filing with the SEC. Broadfin Capital Llc bought 559,471 shares as the company’s stock declined 38.27% with the market. The hedge fund held 2.05M shares of the biological products (no diagnostic substances) company at the end of 2018Q3, valued at $41.35M, up from 1.49 million at the end of the previous reported quarter. Broadfin Capital Llc who had been investing in La Jolla Pharmaceutical Co for a number of months, seems to be bullish on the $159.76 million market cap company. The stock increased 11.74% or $0.64 during the last trading session, reaching $6.09. About 2,225 shares traded. La Jolla Pharmaceutical Company (NASDAQ:LJPC) has declined 56.94% since January 10, 2018 and is downtrending. It has underperformed by 56.94% the S&P500. Some Historical LJPC News: 01/05/2018 – CalciMedica Names Two Senior Executives to its Board of Directors; 22/03/2018 – La Jolla Pharmaceutical Company Announces Launch of GIAPREZA™ (angiotensin Il) in the United States; 20/04/2018 – DJ La Jolla Pharmaceutical Company, Inst Holders, 1Q 2018 (LJPC); 17/05/2018 – La Jolla Pharmaceutical Company Announces LJPC-401 Presentations at 23rd Congress of the European Hematology Association; 14/03/2018 – La Jolla Band of Luiseño Indians selects Win Technologies USA for new casino property; 10/05/2018 – LA JOLLA PHARMACEUTICAL CO. REPORTS $125M ROYALTY FINANCING PAC; 16/05/2018 – California’s First Accredited Geriatric Emergency Department Arrives in La Jolla; 06/03/2018 – GIAPREZA™ (angiotensin Il) Significantly Improved Survival and Reduced Time on Renal Replacement Therapy in Patients with Acute Kidney Injury; 05/03/2018 Pure Spectrum CBD Retail Store Opens in La Jolla, California; 15/03/2018 – LA JOLLA PHARMACEUTICAL CO. REPORTS PRICING OF OFFERING OF

Quaker Capital Investments Llc increased its stake in Range Res Corp (RRC) by 1.2% based on its latest 2018Q3 regulatory filing with the SEC. Quaker Capital Investments Llc bought 21,000 shares as the company’s stock declined 9.27% with the market. The institutional investor held 1.76M shares of the oil & gas production company at the end of 2018Q3, valued at $29.97B, up from 1.74M at the end of the previous reported quarter. Quaker Capital Investments Llc who had been investing in Range Res Corp for a number of months, seems to be bullish on the $2.84B market cap company. The stock increased 5.45% or $0.6 during the last trading session, reaching $11.6. About 11.72 million shares traded or 47.48% up from the average. Range Resources Corporation (NYSE:RRC) has declined 17.18% since January 10, 2018 and is downtrending. It has underperformed by 17.18% the S&P500. Some Historical RRC News: 20/03/2018 – RANGE RESOURCES LTD RRS.AX – RANGE RESOURCES DRILLING SERVICES LIMITED AWARDED A CONTRACT WITH A UNIT OF ROYAL DUTCH SHELL PLC; 25/04/2018 – RANGE RESOURCES CORP – RANGE IS ON TARGET WITH ITS $941 MLN CAPITAL BUDGET FOR 2018; 27/03/2018 – RANGE RESOURCES CORP RRC.N : BERNSTEIN CUTS TO MARKET PERFORM FROM OUTPERFORM; 25/04/2018 – RANGE RESOURCES LTD – INFORMED BY OPERATOR OF AN INCIDENT AT PERLAK OILFIELD IN INDONESIA; 12/04/2018 – Range Announces Retirement of Executive Vice President and COO Ray N. Walker; 27/03/2018 – RRC of Texas: Chairman Craddick Furthers Efficiency, Modernization of RRC – Releases Texas Oilfield Relief Initiative Phase Two; 25/04/2018 – CNBC Wires: Range Resources: 1Q Earnings Snapshot; 02/04/2018 – Range Resources Closes Below 50-Day Moving Average: Technicals; 10/04/2018 – RRC of Texas: RRC COMMISSIONERS APPOINT EXECUTIVE DIRECTOR; 29/05/2018 – Range Resources Starts Operations at Indonesia Project

Investors sentiment increased to 0.88 in Q3 2018. Its up 0.02, from 0.86 in 2018Q2. It increased, as 37 investors sold RRC shares while 124 reduced holdings. 54 funds opened positions while 88 raised stakes. 239.31 million shares or 1.82% less from 243.74 million shares in 2018Q2 were reported. Oarsman Capital invested in 208,415 shares. Creative Planning reported 22,783 shares stake. Moreover, Adage Cap Gru Ltd Company has 0.04% invested in Range Resources Corporation (NYSE:RRC). Quantitative Invest Mngmt Lc holds 200,000 shares or 0.12% of its portfolio. Primecap Ca holds 1.05M shares. 1.87 million are held by Northern. Kingfisher Capital Ltd Limited Liability Company has 0.43% invested in Range Resources Corporation (NYSE:RRC). Nordea Inv Mgmt Ab accumulated 0.01% or 172,800 shares. Metropolitan Life Ins Co owns 59,183 shares or 0.02% of their US portfolio. The Florida-based Kopernik Glob Ltd Company has invested 14.51% in Range Resources Corporation (NYSE:RRC). State Of Tennessee Treasury Department, Tennessee-based fund reported 100,000 shares. The New York-based Mutual Of America Capital Mgmt Ltd Liability has invested 0.12% in Range Resources Corporation (NYSE:RRC). Hsbc Holdings Public Ltd has 38,179 shares. Texas Permanent School Fund reported 0.03% stake. 697,571 were accumulated by Morgan Stanley.

More important recent Range Resources Corporation (NYSE:RRC) news were published by: Investorplace.com which released: “Chesapeake Energy Stock Is Still a High-Reward, High-Risk Name – Investorplace.com” on December 14, 2018, also Benzinga.com published article titled: “Benzinga’s Top Upgrades, Downgrades For January 8, 2019 – Benzinga”, Globenewswire.com published: “Range Announces Appalachian Overriding Royalty Sale for $300 Million – GlobeNewswire” on October 15, 2018. More interesting news about Range Resources Corporation (NYSE:RRC) was released by: Seekingalpha.com and their article: “S&P indexes swap firms due to shifting market caps; FSB to SmallCap 600 – Seeking Alpha” with publication date: June 08, 2018.

Quaker Capital Investments Llc, which manages about $309.57B US Long portfolio, decreased its stake in Dowdupont Inc by 2,500 shares to 11,450 shares, valued at $736.35M in 2018Q3, according to the filing.

Since September 6, 2018, it had 1 buying transaction, and 0 selling transactions for $7,197 activity.

Among 46 analysts covering Range Resources Corp. (NYSE:RRC), 25 have Buy rating, 3 Sell and 18 Hold. Therefore 54% are positive. Range Resources Corp. had 162 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was downgraded by Nomura to “Neutral” on Wednesday, June 8. On Wednesday, January 25 the stock rating was initiated by R. F. Lafferty with “Buy”. Morgan Stanley initiated Range Resources Corporation (NYSE:RRC) on Tuesday, September 20 with “Equal-Weight” rating. As per Friday, September 8, the company rating was downgraded by Goldman Sachs. JP Morgan maintained it with “Neutral” rating and $44 target in Monday, May 2 report. The rating was maintained by Bank of America with “Neutral” on Thursday, January 25. The stock of Range Resources Corporation (NYSE:RRC) has “Overweight” rating given on Friday, October 7 by JP Morgan. Cowen & Co maintained Range Resources Corporation (NYSE:RRC) rating on Friday, November 3. Cowen & Co has “Buy” rating and $30.0 target. The firm has “Hold” rating given on Monday, October 23 by J.P. Morgan. Barclays Capital maintained it with “Sell” rating and $26 target in Friday, April 21 report.

More notable recent La Jolla Pharmaceutical Company (NASDAQ:LJPC) news were published by: Investorplace.com which released: “2 Stable and 2 Speculative Biotech Stocks to Buy – Investorplace.com” on June 15, 2018, also Seekingalpha.com with their article: “Stocks To Watch: CES Headlines Action-Packed Week – Seeking Alpha” published on January 05, 2019, 247Wallst.com published: “PG&E, AxoGen Tumble into Tuesday’s 52-Week Low Club – 24/7 Wall St.” on January 08, 2019. More interesting news about La Jolla Pharmaceutical Company (NASDAQ:LJPC) were released by: Globenewswire.com and their article: “Research Report Identifies Exelon, La Jolla Pharmaceutical, Kennedy-Wilson, Fluidigm, Telefonica SA, and Cognex with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement – GlobeNewswire” published on November 06, 2018 as well as Benzinga.com‘s news article titled: “Analyst: La Jolla Pharma (NASDAQ:LJPC) A Buy Ahead Of February FDA Date – Benzinga” with publication date: December 21, 2017.

Broadfin Capital Llc, which manages about $1.26 billion and $679.52M US Long portfolio, decreased its stake in Kala Pharmaceuticals Inc by 252,503 shares to 346,083 shares, valued at $3.42 million in 2018Q3, according to the filing. It also reduced its holding in Tesaro Inc (NASDAQ:TSRO) by 20,300 shares in the quarter, leaving it with 104,700 shares, and cut its stake in Livanova Plc.

Investors sentiment decreased to 1.23 in Q3 2018. Its down 0.27, from 1.5 in 2018Q2. It fall, as 15 investors sold LJPC shares while 16 reduced holdings. 10 funds opened positions while 28 raised stakes. 32.70 million shares or 8.66% more from 30.09 million shares in 2018Q2 were reported. New York State Common Retirement Fund has invested 0% in La Jolla Pharmaceutical Company (NASDAQ:LJPC). State Street Corp accumulated 1.65 million shares. Moreover, Tower Capital Limited Liability Co (Trc) has 0.01% invested in La Jolla Pharmaceutical Company (NASDAQ:LJPC) for 4,241 shares. Rhumbline Advisers has 18,530 shares for 0% of their portfolio. Schwab Charles Mngmt Inc reported 106,580 shares. Jpmorgan Chase And Communication has 138,417 shares. Alyeska Invest LP holds 125,000 shares or 0.03% of its portfolio. Perceptive Advisors Limited Liability Corporation owns 4.31 million shares or 2.32% of their US portfolio. California State Teachers Retirement Sys reported 32,815 shares stake. Us Fincl Bank De invested in 626 shares or 0% of the stock. First Midwest Natl Bank Trust Division owns 38,008 shares. State Board Of Administration Of Florida Retirement System, a Florida-based fund reported 14,575 shares. Hollencrest Management has invested 0.02% in La Jolla Pharmaceutical Company (NASDAQ:LJPC). Sectoral Asset Mgmt Inc holds 3.52% in La Jolla Pharmaceutical Company (NASDAQ:LJPC) or 1.65 million shares. California Employees Retirement holds 0% or 31,900 shares.

Among 8 analysts covering La Jolla Pharmaceutical Company (NASDAQ:LJPC), 5 have Buy rating, 3 Sell and 0 Hold. Therefore 63% are positive. La Jolla Pharmaceutical Company had 22 analyst reports since August 11, 2015 according to SRatingsIntel. The firm has “Hold” rating by Zacks given on Tuesday, August 11. The firm has “Underperform” rating given on Thursday, August 9 by Jefferies. As per Tuesday, February 9, the company rating was initiated by Cowen & Co. The firm has “Underweight” rating given on Friday, August 10 by JP Morgan. The stock has “Buy” rating by Jefferies on Monday, June 12. Lake Street initiated the shares of LJPC in report on Tuesday, May 24 with “Buy” rating. The company was downgraded on Monday, February 12 by Jefferies. The firm has “Buy” rating given on Thursday, August 31 by Jefferies. J.P. Morgan initiated the stock with “Buy” rating in Wednesday, August 30 report. The company was maintained on Tuesday, January 30 by H.C. Wainwright.

Since August 16, 2018, it had 2 insider purchases, and 0 sales for $42,892 activity. 1,000 shares were bought by Rolke James, worth $21,997.

Range Resources Corporation (NYSE:RRC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.